IMMUPHARMA PLC — Major Shareholding Notification 2016

Nov 9, 2016

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6800O

Immupharma PLC

09 November 2016

RNS : FOR IMMEDIATE RELEASE	9 NOVEMBER 2016

NOTIFICATION OF MAJOR INTEREST BY LEGAL & GENERAL

ImmuPharma PLC (LSE:IMM) ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, announces that it has received notification by Legal & General Group Plc ("L&G") confirming its holding in ImmuPharma of 4,285,714 million Ordinary Shares in the capital of the Company, representing 3.43% of ImmuPharma's total voting rights.

Commenting, Tim McCarthy, Chairman of ImmuPharma, said: "We are delighted to be able to disclose Legal & General as one of the new significant and major institutional investors which participated in ImmuPharma's recent successful vendor placing. One of the Board's priorities is to maintain and strengthen our shareholder base. We are therefore delighted that such a highly regarded institution as Legal & General has demonstrated its support for ImmuPharma."

Full disclosure of the TR1 is shown below:

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:			Immupharma Plc
2. Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights				Yes
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached.
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights				Yes
Other (please specify):	Placement of 2,857,143 shares
3. Full name of person(s) subject to the notification obligation:		Legal & General Group Plc (L&G)
4. Full name of shareholder(s) (if different from 3.):		Legal & General Assurance Society Limited (LGAS & LGPL)
5. Date of the transaction and date on which the threshold is crossed or reached:		21 October 2016
6. Date on which issuer notified:		28 October 2016
7. Threshold(s) that is/are crossed or reached:		L&G (Above 3%)

8. Notified details:
A: Voting rights attached to shares
Class/type of shares if possible using the ISIN CODE	Situation previous to the triggering transaction							Resulting situation after the triggering transaction
Number of Shares			Number of Voting Rights				Number of shares		Number of voting rights				% of  voting rights
Direct		Indirect		Direct		Indirect
ORD GBP 0.10	First notification under DTR Sourcebook							4,285,714		4,285,714		-		3.43%		-
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument			Expiration date			Exercise/ Conversion Period					Number of voting rights that may be acquired if the instrument is exercised/ converted.				% of voting rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument		Exercise price			Expiration date		Exercise/ Conversion period		Number of voting rights instrument refers to				% of voting rights
													Nominal			Delta
Total (A+B+C)
Number of voting rights									Percentage of voting rights
4,285,714									3.43%

9. Chain of controlled undertakings through which the voting rights and/or the

financial instruments are effectively held, if applicable:

Legal & General Group Plc (Direct and Indirect) (Group) (Below 5% = Total Position)
Legal & General Investment Management (Holdings) Limited (LGIMH) (Direct and Indirect)  (Below 5% = Total Position)
Legal & General Investment Management Limited (Indirect) (LGIM) (Below 5% = Total Position)
Legal & General Group Plc (Direct) (L&G) (4,285,714, 3.43% = LGAS, LGPL & PMC)
Legal & General Investment Management (Holdings) Limited (Direct) (LGIMHD)	Legal & General Insurance Holdings Limited (Direct) (LGIH) (4,285,714, 3.43% = LGAS & LGPL)
Legal & General Assurance (Pensions Management) Limited  (PMC)	Legal & General Assurance Society Limited  (LGAS & LGPL) (4,285,714, 3.43% = LGAS & LGPL)
	Legal & General Pensions Limited (Direct)  (LGPL)

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease

to hold:

N/A

12. Date on which proxy holder will cease to hold

voting rights:

N/A

13. Additional information:

Notification using the total voting rights figure of 124,638,362

14. Contact name:

Victoria Davies (LGIM)

15. Contact telephone number:

029 2035 4147

-Ends-

For further information please contact:

ImmuPharma plc (www.immupharma.org)	+ 44 (0) 20 7152 4080
Tim McCarthy, Chairman
Lisa Baderoon, Head of Investor Relations Twitter: @immupharma	+ 44 (0) 7721 413496
Panmure, Gordon & Co., (NOMAD & Broker)	+44 (0) 20 7886 2500
Freddy Crossley, Duncan Monteith, Corporate Finance Charles Leigh-Pemberton, Corporate Broking Northland Capital Partners Limited (Joint Broker) Patrick Claridge, David Hignell, Corporate Finance Rob Rees, John Howes, Corporate Broking	+44 (0)20 3861 6625

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLBVLLBQFFLFBQ